Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12751 | 883 | 40.2 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
419 | 2 | STATINS//EZETIMIBE//SIMVASTATIN | 16502 |
12751 | 1 | NIACIN//LAROPIPRANT//GPR109A | 883 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NIACIN | authKW | 2457317 | 25% | 32% | 224 |
2 | LAROPIPRANT | authKW | 1429060 | 5% | 92% | 45 |
3 | GPR109A | authKW | 868990 | 4% | 74% | 34 |
4 | NICOTINIC ACID | authKW | 739424 | 13% | 18% | 118 |
5 | EXTENDED RELEASE NIACIN | authKW | 731707 | 3% | 92% | 23 |
6 | HM74A | authKW | 658663 | 2% | 95% | 20 |
7 | NICOTINIC ACID RECEPTOR | authKW | 314361 | 1% | 91% | 10 |
8 | NICOTINURIC ACID | authKW | 254631 | 1% | 82% | 9 |
9 | PUMA G | authKW | 245900 | 1% | 89% | 8 |
10 | HCA2 | authKW | 201188 | 1% | 73% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 2065 | 20% | 0% | 175 |
2 | Pharmacology & Pharmacy | 1440 | 25% | 0% | 222 |
3 | Medicine, General & Internal | 787 | 15% | 0% | 133 |
4 | Peripheral Vascular Diseases | 747 | 9% | 0% | 81 |
5 | Endocrinology & Metabolism | 262 | 8% | 0% | 69 |
6 | Chemistry, Medicinal | 245 | 6% | 0% | 50 |
7 | Medicine, Research & Experimental | 109 | 5% | 0% | 47 |
8 | Primary Health Care | 96 | 1% | 0% | 10 |
9 | Nutrition & Dietetics | 61 | 3% | 0% | 25 |
10 | Biochemistry & Molecular Biology | 35 | 10% | 0% | 90 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VIS SCI DISCOVERY | 69160 | 0% | 100% | 2 |
2 | VET AFFAIRS HEALTHCARE SYST | 40332 | 1% | 17% | 7 |
3 | ACCREDITAT COUNCIL CLIN LIPIDOL CERTIFIED CLIN | 34580 | 0% | 100% | 1 |
4 | ADIPOSE TISSUE SIGNALING | 34580 | 0% | 100% | 1 |
5 | ALGEMEEN ZIEKENHUIS STUIVENBERG | 34580 | 0% | 100% | 1 |
6 | ALLLIED HLTH SCI | 34580 | 0% | 100% | 1 |
7 | ARBEITSBEREICH LIPISTOFFWECHSEL | 34580 | 0% | 100% | 1 |
8 | ATORVASTAT CARDIOVASC GRP | 34580 | 0% | 100% | 1 |
9 | CARDIAC REHABILAT CHOLESTEROL CLIN | 34580 | 0% | 100% | 1 |
10 | CARDIOVASC DIABETS OBESITY METAB | 34580 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL LIPIDOLOGY | 33202 | 3% | 4% | 25 |
2 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 5670 | 1% | 1% | 13 |
3 | AMERICAN JOURNAL OF CARDIOLOGY | 4317 | 7% | 0% | 58 |
4 | CURRENT ATHEROSCLEROSIS REPORTS | 3332 | 1% | 1% | 8 |
5 | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2674 | 2% | 0% | 18 |
6 | CURRENT OPINION IN LIPIDOLOGY | 2592 | 1% | 1% | 10 |
7 | CLINICAL LIPIDOLOGY | 2253 | 1% | 1% | 5 |
8 | ATHEROSCLEROSIS | 1689 | 3% | 0% | 23 |
9 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 1306 | 0% | 1% | 4 |
10 | ARTERY | 1036 | 0% | 1% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NIACIN | 2457317 | 25% | 32% | 224 | Search NIACIN | Search NIACIN |
2 | LAROPIPRANT | 1429060 | 5% | 92% | 45 | Search LAROPIPRANT | Search LAROPIPRANT |
3 | GPR109A | 868990 | 4% | 74% | 34 | Search GPR109A | Search GPR109A |
4 | NICOTINIC ACID | 739424 | 13% | 18% | 118 | Search NICOTINIC+ACID | Search NICOTINIC+ACID |
5 | EXTENDED RELEASE NIACIN | 731707 | 3% | 92% | 23 | Search EXTENDED+RELEASE+NIACIN | Search EXTENDED+RELEASE+NIACIN |
6 | HM74A | 658663 | 2% | 95% | 20 | Search HM74A | Search HM74A |
7 | NICOTINIC ACID RECEPTOR | 314361 | 1% | 91% | 10 | Search NICOTINIC+ACID+RECEPTOR | Search NICOTINIC+ACID+RECEPTOR |
8 | NICOTINURIC ACID | 254631 | 1% | 82% | 9 | Search NICOTINURIC+ACID | Search NICOTINURIC+ACID |
9 | PUMA G | 245900 | 1% | 89% | 8 | Search PUMA+G | Search PUMA+G |
10 | HCA2 | 201188 | 1% | 73% | 8 | Search HCA2 | Search HCA2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JACOBSON, TA , (2010) A "HOT" TOPIC IN DYSLIPIDEMIA MANAGEMENT-"HOW TO BEAT A FLUSH": OPTIMIZING NIACIN TOLERABILITY TO PROMOTE LONG-TERM TREATMENT ADHERENCE AND CORONARY DISEASE PREVENTION.MAYO CLINIC PROCEEDINGS. VOL. 85. ISSUE 4. P. 365 -379 | 94 | 76% | 27 |
2 | GOUNI-BERTHOLD, I , BERTHOLD, HK , (2013) THE ROLE OF NIACIN IN LIPID-LOWERING TREATMENT: ARE WE AIMING TOO HIGH?.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 17. P. 3094-3106 | 87 | 79% | 5 |
3 | OFFERMANNS, S , COLLETTI, SL , LOVENBERG, TW , SEMPLE, G , WISE, A , IJZERMAN, AP , (2011) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXII: NOMENCLATURE AND CLASSIFICATION OF HYDROXY-CARBOXYLIC ACID RECEPTORS (GPR81, GPR109A, AND GPR109B).PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 2. P. 269-290 | 78 | 71% | 46 |
4 | KEI, A , ELISAF, MS , (2012) NICOTINIC ACID: CLINICAL CONSIDERATIONS.EXPERT OPINION ON DRUG SAFETY. VOL. 11. ISSUE 4. P. 551-564 | 68 | 81% | 7 |
5 | SHEN, HC , COLLETTI, SL , (2010) HIGH-AFFINITY NIACIN RECEPTOR GPR109A AGONISTS.ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45. VOL. 45. ISSUE . P. 73-+ | 54 | 89% | 7 |
6 | KEI, A , LIBEROPOULOS, EN , ELISAF, MS , (2011) WHAT RESTRICTS THE CLINICAL USE OF NICOTINIC ACID?.CURRENT VASCULAR PHARMACOLOGY. VOL. 9. ISSUE 4. P. 521-530 | 65 | 67% | 1 |
7 | VILLINES, TC , KIM, AS , GORE, RS , TAYLOR, AJ , (2012) NIACIN: THE EVIDENCE, CLINICAL USE, AND FUTURE DIRECTIONS.CURRENT ATHEROSCLEROSIS REPORTS. VOL. 14. ISSUE 1. P. 49-59 | 51 | 76% | 21 |
8 | TANG, C , OFFERMANNS, S , BLAD, CC , (2012) G PROTEIN-COUPLED RECEPTORS FOR ENERGY METABOLITES AS NEW THERAPEUTIC TARGETS.NATURE REVIEWS DRUG DISCOVERY. VOL. 11. ISSUE 8. P. 603 -619 | 86 | 38% | 58 |
9 | SONG, WL , FITZGERALD, GA , (2013) THEMATIC REVIEW SERIES: NEW LIPID AND LIPOPROTEIN TARGETS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES NIACIN, AN OLD DRUG WITH A NEW TWIST.JOURNAL OF LIPID RESEARCH. VOL. 54. ISSUE 10. P. 2586 -2594 | 59 | 61% | 10 |
10 | LUKASOVA, M , HANSON, J , TUNARU, S , OFFERMANNS, S , (2011) NICOTINIC ACID (NIACIN): NEW LIPID-INDEPENDENT MECHANISMS OF ACTION AND THERAPEUTIC POTENTIALS.TRENDS IN PHARMACOLOGICAL SCIENCES. VOL. 32. ISSUE 12. P. 700-707 | 48 | 74% | 32 |
Classes with closest relation at Level 1 |